Correction: S100A9+ MDSC and TAM-mediated EGFR-TKI Resistance in Lung Adenocarcinoma: The Role of RELB

Oncotarget - United States
doi 10.18632/oncotarget.25943
Full Text
Abstract

Available in full text

Categories
Oncology
Date
Authors
Publisher

Impact Journals, LLC

Related search

P063 STE029 Overcomes EGFR-TKI Resistance in Human Lung Adenocarcinoma

Journal of Thoracic Oncology
MedicineOncologyRespiratory MedicinePulmonary
2018English

Acquired Resistance Mechanisms to Combination Met-Tki/Egfr-Tki Exposure in Met-Amplified EGFR-TKI–Resistant Lung Adenocarcinoma Harboring an Activating EGFR Mutation

Molecular Cancer Therapeutics
Cancer ResearchOncology
2016English

P3.01-002 Concurrent EGFR T790M Secondary Mutation and EMT in a Lung Adenocarcinoma Patient With EGFR TKI Drug Resistance

Journal of Thoracic Oncology
MedicineOncologyRespiratory MedicinePulmonary
2017English

EGFR-TKI and Lung Adenocarcinoma With CNS Relapse: Interest of Molecular Follow-Up

European Respiratory Journal
MedicinePulmonaryRespiratory Medicine
2008English

Case Report: Temporal Heterogeneity of Resistance Mechanisms to EGFR-TKI Identified in a Lung Adenocarcinoma Patient With Sarcomatoid Transformation

Clinical Lung Cancer
Cancer ResearchOncologyRespiratory MedicinePulmonary
2020English

Combined Therapy With EGFR TKI and Gambogic Acid for Overcoming Resistance in EGFR‑T790M Mutant Lung Cancer

Oncology Letters
Cancer ResearchOncology
2015English

Analysis of Tumor Specimens at the Time of Acquired Resistance to EGFR-TKI Therapy in 155 Patients With EGFR-Mutant Lung Cancers

Clinical Cancer Research
Cancer ResearchOncology
2013English

EGFR Inhibitors in Treatment of Lung Adenocarcinoma

Research in Oncology
2014English

P3.cr-09 MET-UBE2H Fusion as a Novel Mechanism of Acquired EGFR Resistance in Lung Adenocarcinoma" With "MET Fusion as a Novel Mechanism of Acquired EGFR Resistance in Lung Adenocarcinoma

Journal of Thoracic Oncology
MedicineOncologyRespiratory MedicinePulmonary
2018English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy